Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), sold 6,922 shares at $39.59 ($277K) on 2021-12-16, disclosed to the SEC on 2021-12-20.
Open-market sale of $277k RCUS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.59 | 1,680 | $67K | 24.0% |
| 2 | $39.59 | 1,680 | $67K | 24.0% |
| 3 | $40.46 | 619 | $25K | 9.0% |
| 4 | $38.79 | 653 | $25K | 9.1% |
| 5 | $39.67 | 417 | $17K | 6.0% |
| 6 | $40.57 | 808 |
| $33K |
| 11.8% |
| 7 | $41.42 | 1,065 | $44K | 15.9% |
| Total | $39.99 avg | 6,922 | $277K | 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-06-21 | $418K | — | Filing → |